Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeymatm, a ...

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals. -- Vir Biotechnology's chronic hepatitis delta ...

On the same day, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive ...

Pharma agreement represents a missed opportunity to boost innovation and competitiveness, says Belgian industry ...

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Minjuvi ® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with ...

Depemokimab has been approved by the MHRA as the first and only biologic with twice-yearly dosing to treat asthma and severe ...

India and Oman are set to sign a Comprehensive Economic Partnership Agreement on December 18, aiming to deepen economic ties ...

The European Medicines Agency has endorsed a deal between the European Commission, the European Parliament and the Council of ...

Incyte (INCY) announced that the European Commission has approved Minjuvi in combination with lenalidomide and rituximab for the treatment of ...

Across major agencies, the past fortnight brought a steady cadence of regulatory decisions, committee opinions, and ...

Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention ...